Wi-Fi standards remain as confusing as ever.
Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
Findings provide mechanistic support for previously reported clinical outcomes of clinical reversal of platinum resistance/refractoriness from ...
Cohere Technologies was awarded a $28 million contract by the Department of Defense (DoD) to develop radio access network (RAN) technologies to advance 5G/6G infrastructure. The contract will support ...
Epicrispr Biotechnologies, a clinical-stage company pioneering epigenetic therapies, today announced new interim data from its ongoing open-label Phase 1/2 first-in-human study of EPI-321 in ...
Optical interconnects, leveraging intrinsic advantages such as high bandwidth, low loss, and immunity to electromagnetic interference (EMI), are thus regarded as a promising solution to these barriers ...
Detailed price information for Allegro Microsystems Inc (ALGM-Q) from The Globe and Mail including charting and trades.
Virginia officially introduced a new mechanism for managing high-risk traffic offenders, shifting the legal parameters for ...
Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with ...
Alzheimer’s blood test breakthrough: 34 circular RNA biomarkers validated in nearly 2,400 patients outperform the pTau217 ...
FS introduces 800G ZR/ZR+ coherent optical modules, enabling high-capacity transport and efficient connectivity for AI scale-across and DCI networks.
Fine-scale exogenous attention within the foveola selectively enhances contrast gain at low-to-mid spatial frequencies while increasing response gain across a broad spatial frequency range.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results